RT @bradpalm1: Synthonics has received final approval from the FDA and University of Chicago to proceed with a Phase I clinical trial testi…
135 followers
304 followers
Synthonics has received final approval from the FDA and University of Chicago to proceed with a Phase I clinical trial testing a novel sustained release-T3 drug (PZL) next spring. If approved could significantly help treat patients with hypothyroidism. htt
304 followers
Sustained Release T3 Therapy: Animal Models and Translational Applications https://t.co/9C0XH1ULLA
304 followers
Sustained release T3 therapy: animal models and translational applications https://t.co/9C0XH1ULLA